Stavros G. Vizirgianakis - Aug 25, 2022 Form 3 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
Director
Signature
/s/ Amy Culbert, attorney-in-fact
Stock symbol
XTNT
Transactions as of
Aug 25, 2022
Transactions value $
$0
Form type
3
Date filed
8/26/2022, 04:31 PM
Previous filing
Jun 22, 2022
Next filing
Oct 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XTNT Common Stock, $0.000001 par value 3.52M Aug 25, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding XTNT Warrant Aug 25, 2022 Common Stock 879K $0.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 3,515,079 shares issued in connection with the first closing of the private placement (the "Private Placement") pursuant to the securities purchase agreement by and among Xtant Medical Holdings, Inc. and several accredited investors. Does not include 2,264,861 shares to be issued in connection with the second closing of the Private Placement, which will be issued subject to the satisfaction of certain closing conditions.
F2 Consists of a warrant to purchase 878,770 shares in connection with the first closing of the Private Placement. Does not include a warrant to purchase 566,214 shares to be issued in connection with the second closing of the Private Placement, which will be issued subject to the satisfaction of certain closing conditions.